Concepts (232)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cryptococcosis | 23 | 2015 | 36 | 8.170 |
Why?
|
| Cryptococcus neoformans | 24 | 2015 | 56 | 7.570 |
Why?
|
| Lung Diseases, Fungal | 12 | 2015 | 20 | 3.650 |
Why?
|
| Macrophage Activation | 7 | 2015 | 56 | 2.250 |
Why?
|
| Fungal Vaccines | 7 | 2015 | 41 | 1.800 |
Why?
|
| Mice, Inbred BALB C | 19 | 2015 | 661 | 1.520 |
Why?
|
| STAT1 Transcription Factor | 3 | 2015 | 35 | 1.430 |
Why?
|
| T-Lymphocytes | 7 | 2012 | 357 | 1.400 |
Why?
|
| Host-Pathogen Interactions | 5 | 2015 | 186 | 1.370 |
Why?
|
| Lung | 8 | 2015 | 446 | 1.330 |
Why?
|
| Interleukin-17 | 5 | 2014 | 53 | 1.320 |
Why?
|
| Macrophages, Alveolar | 4 | 2015 | 34 | 1.180 |
Why?
|
| Fungal Proteins | 4 | 2014 | 140 | 1.130 |
Why?
|
| Candidiasis, Vulvovaginal | 8 | 2014 | 9 | 1.070 |
Why?
|
| Mice | 34 | 2015 | 5913 | 1.040 |
Why?
|
| Immunity, Cellular | 8 | 2015 | 70 | 0.910 |
Why?
|
| Cryptococcus gattii | 2 | 2014 | 7 | 0.900 |
Why?
|
| Lung Diseases | 3 | 2014 | 61 | 0.850 |
Why?
|
| Animals | 37 | 2015 | 15081 | 0.800 |
Why?
|
| Antibodies, Fungal | 5 | 2010 | 23 | 0.750 |
Why?
|
| Neutrophils | 3 | 2012 | 131 | 0.670 |
Why?
|
| Interferon-gamma | 5 | 2010 | 250 | 0.670 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 2 | 2012 | 16 | 0.640 |
Why?
|
| Antigens, Fungal | 3 | 2013 | 31 | 0.600 |
Why?
|
| Vagina | 6 | 2012 | 81 | 0.560 |
Why?
|
| Candida albicans | 8 | 2014 | 164 | 0.550 |
Why?
|
| Cytokines | 11 | 2015 | 602 | 0.540 |
Why?
|
| Th1 Cells | 8 | 2014 | 92 | 0.530 |
Why?
|
| Female | 31 | 2015 | 20969 | 0.520 |
Why?
|
| Disease Models, Animal | 14 | 2015 | 1371 | 0.510 |
Why?
|
| Disease Susceptibility | 2 | 2014 | 97 | 0.490 |
Why?
|
| Cryptococcus | 1 | 2013 | 5 | 0.470 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2012 | 259 | 0.460 |
Why?
|
| Signal Transduction | 4 | 2015 | 1908 | 0.460 |
Why?
|
| Anti-Infective Agents | 1 | 2014 | 64 | 0.460 |
Why?
|
| Microbial Viability | 1 | 2012 | 37 | 0.430 |
Why?
|
| Receptors, Pattern Recognition | 1 | 2012 | 11 | 0.430 |
Why?
|
| Mycoses | 1 | 2012 | 30 | 0.420 |
Why?
|
| Lysosomes | 1 | 2012 | 91 | 0.410 |
Why?
|
| Dendritic Cells | 1 | 2012 | 113 | 0.410 |
Why?
|
| Candidiasis | 3 | 2014 | 84 | 0.400 |
Why?
|
| Peptides | 1 | 2014 | 320 | 0.390 |
Why?
|
| Calcineurin | 3 | 2005 | 22 | 0.380 |
Why?
|
| Mice, Knockout | 5 | 2014 | 933 | 0.360 |
Why?
|
| Biofilms | 2 | 2009 | 168 | 0.350 |
Why?
|
| Immunodominant Epitopes | 1 | 2009 | 27 | 0.340 |
Why?
|
| Environment | 1 | 2009 | 138 | 0.300 |
Why?
|
| Vaccination | 4 | 2013 | 288 | 0.290 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2014 | 182 | 0.290 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 2014 | 421 | 0.280 |
Why?
|
| Nitric Oxide | 3 | 2015 | 316 | 0.270 |
Why?
|
| Th2 Cells | 5 | 2014 | 58 | 0.260 |
Why?
|
| Virulence | 6 | 2014 | 223 | 0.250 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2005 | 118 | 0.250 |
Why?
|
| Survival Analysis | 3 | 2015 | 325 | 0.240 |
Why?
|
| Flow Cytometry | 3 | 2014 | 399 | 0.240 |
Why?
|
| Lymphocyte Activation | 3 | 2001 | 236 | 0.230 |
Why?
|
| Humans | 16 | 2015 | 37093 | 0.230 |
Why?
|
| Cell Wall | 2 | 2013 | 53 | 0.220 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 2014 | 78 | 0.210 |
Why?
|
| Vaginitis | 1 | 2001 | 1 | 0.210 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 539 | 0.200 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 2001 | 2 | 0.200 |
Why?
|
| Cell Adhesion Molecules | 1 | 2001 | 75 | 0.190 |
Why?
|
| Mutation | 7 | 2015 | 1095 | 0.190 |
Why?
|
| Chemokines | 3 | 2012 | 97 | 0.190 |
Why?
|
| Cytoprotection | 2 | 2011 | 36 | 0.190 |
Why?
|
| Transcription Factors | 1 | 2005 | 681 | 0.180 |
Why?
|
| Inflammation | 2 | 2015 | 618 | 0.180 |
Why?
|
| Macrophages | 3 | 2015 | 439 | 0.170 |
Why?
|
| Fungi | 2 | 2012 | 89 | 0.170 |
Why?
|
| Mice, Inbred CBA | 4 | 2002 | 38 | 0.160 |
Why?
|
| Gene Expression Regulation, Fungal | 3 | 2015 | 74 | 0.160 |
Why?
|
| Organisms, Genetically Modified | 2 | 2010 | 5 | 0.160 |
Why?
|
| Cells, Cultured | 3 | 2012 | 1518 | 0.160 |
Why?
|
| Antifungal Agents | 2 | 2012 | 148 | 0.150 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 1015 | 0.150 |
Why?
|
| Interleukins | 2 | 2014 | 29 | 0.150 |
Why?
|
| Virulence Factors | 2 | 2014 | 113 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 3 | 2010 | 1609 | 0.140 |
Why?
|
| Mouth Mucosa | 2 | 2014 | 34 | 0.140 |
Why?
|
| Administration, Intranasal | 2 | 2014 | 79 | 0.130 |
Why?
|
| Immunoglobulins | 2 | 2009 | 37 | 0.130 |
Why?
|
| Hyphae | 1 | 2015 | 36 | 0.130 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2015 | 115 | 0.130 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2015 | 47 | 0.130 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2014 | 10 | 0.130 |
Why?
|
| Urothelium | 1 | 2014 | 8 | 0.130 |
Why?
|
| Meningitis, Cryptococcal | 1 | 2014 | 2 | 0.120 |
Why?
|
| Meningoencephalitis | 1 | 2014 | 12 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 623 | 0.120 |
Why?
|
| Acute-Phase Proteins | 1 | 2014 | 14 | 0.120 |
Why?
|
| Immunoblotting | 1 | 2014 | 176 | 0.120 |
Why?
|
| Cell Fractionation | 1 | 2013 | 30 | 0.120 |
Why?
|
| Receptors, Immunologic | 1 | 2014 | 61 | 0.120 |
Why?
|
| Immunocompromised Host | 1 | 2013 | 22 | 0.120 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2014 | 62 | 0.120 |
Why?
|
| Leukocytes | 2 | 2015 | 72 | 0.120 |
Why?
|
| Intestinal Mucosa | 1 | 2014 | 122 | 0.120 |
Why?
|
| Mice, Transgenic | 1 | 2015 | 617 | 0.110 |
Why?
|
| Cytoplasm | 1 | 2013 | 143 | 0.110 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2013 | 132 | 0.110 |
Why?
|
| Osmosis | 1 | 2012 | 8 | 0.110 |
Why?
|
| Intracellular Space | 1 | 2012 | 35 | 0.110 |
Why?
|
| Cell Extracts | 1 | 2012 | 16 | 0.110 |
Why?
|
| Analysis of Variance | 1 | 2014 | 550 | 0.110 |
Why?
|
| Cathepsin B | 1 | 2012 | 26 | 0.110 |
Why?
|
| Reactive Oxygen Species | 1 | 2015 | 461 | 0.110 |
Why?
|
| Immunophenotyping | 1 | 2012 | 57 | 0.110 |
Why?
|
| Protease Inhibitors | 1 | 2012 | 49 | 0.110 |
Why?
|
| Bone Marrow Cells | 1 | 2012 | 81 | 0.110 |
Why?
|
| Lectins, C-Type | 1 | 2012 | 36 | 0.110 |
Why?
|
| Proteome | 1 | 2013 | 144 | 0.110 |
Why?
|
| Fatal Outcome | 1 | 2011 | 40 | 0.100 |
Why?
|
| Autopsy | 1 | 2011 | 43 | 0.100 |
Why?
|
| New Mexico | 1 | 2011 | 31 | 0.100 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2012 | 201 | 0.100 |
Why?
|
| Congresses as Topic | 1 | 2011 | 42 | 0.100 |
Why?
|
| Tetracycline | 1 | 2011 | 17 | 0.100 |
Why?
|
| Lymphocyte Depletion | 1 | 2011 | 13 | 0.100 |
Why?
|
| Phosphorylation | 1 | 2014 | 928 | 0.100 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2011 | 22 | 0.100 |
Why?
|
| Candidiasis, Oral | 2 | 2002 | 23 | 0.100 |
Why?
|
| Vaccines, Attenuated | 2 | 2015 | 72 | 0.090 |
Why?
|
| Transgenes | 1 | 2010 | 59 | 0.090 |
Why?
|
| Temperature | 2 | 2009 | 286 | 0.090 |
Why?
|
| Saliva | 2 | 2002 | 107 | 0.090 |
Why?
|
| Interleukin-4 | 3 | 2005 | 72 | 0.090 |
Why?
|
| Genotype | 1 | 2011 | 730 | 0.080 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 935 | 0.080 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2009 | 142 | 0.080 |
Why?
|
| Carbon Dioxide | 1 | 2009 | 77 | 0.080 |
Why?
|
| Phylogeny | 1 | 2011 | 644 | 0.080 |
Why?
|
| Brain | 2 | 2015 | 1346 | 0.080 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2009 | 364 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 448 | 0.080 |
Why?
|
| Mice, Inbred A | 1 | 2007 | 7 | 0.070 |
Why?
|
| Cell Culture Techniques | 1 | 2008 | 142 | 0.070 |
Why?
|
| Cell Line | 2 | 2014 | 1354 | 0.070 |
Why?
|
| tert-Butylhydroperoxide | 1 | 2005 | 5 | 0.070 |
Why?
|
| Flocculation | 1 | 2005 | 6 | 0.070 |
Why?
|
| Treatment Outcome | 1 | 2010 | 1369 | 0.070 |
Why?
|
| Hypersensitivity, Delayed | 2 | 2002 | 4 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2009 | 517 | 0.060 |
Why?
|
| Fluconazole | 1 | 2004 | 41 | 0.060 |
Why?
|
| Phagocytosis | 1 | 2005 | 69 | 0.060 |
Why?
|
| Chemokine CCL2 | 1 | 2005 | 85 | 0.060 |
Why?
|
| Mice, Inbred C3H | 1 | 2003 | 84 | 0.060 |
Why?
|
| Blood | 1 | 2003 | 37 | 0.060 |
Why?
|
| Mice, SCID | 1 | 2003 | 150 | 0.060 |
Why?
|
| Stomatitis, Denture | 1 | 2002 | 2 | 0.050 |
Why?
|
| Immunocompetence | 1 | 2002 | 8 | 0.050 |
Why?
|
| Body Fluids | 1 | 2002 | 17 | 0.050 |
Why?
|
| Antibody Specificity | 1 | 2002 | 79 | 0.050 |
Why?
|
| HIV Seronegativity | 2 | 2002 | 39 | 0.050 |
Why?
|
| Mice, Nude | 1 | 2003 | 337 | 0.050 |
Why?
|
| Immunoglobulin A | 1 | 2002 | 58 | 0.050 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2002 | 42 | 0.050 |
Why?
|
| Immunoglobulin M | 1 | 2002 | 82 | 0.050 |
Why?
|
| Enterotoxins | 1 | 2002 | 33 | 0.050 |
Why?
|
| Molecular Sequence Data | 1 | 2005 | 1568 | 0.050 |
Why?
|
| Bacterial Toxins | 1 | 2002 | 44 | 0.050 |
Why?
|
| Nitrogen Oxides | 1 | 2001 | 5 | 0.050 |
Why?
|
| Mucoproteins | 1 | 2001 | 1 | 0.050 |
Why?
|
| L-Selectin | 1 | 2001 | 2 | 0.050 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 2001 | 5 | 0.050 |
Why?
|
| Middle Aged | 4 | 2011 | 10129 | 0.050 |
Why?
|
| Integrin alpha4beta1 | 1 | 2001 | 5 | 0.050 |
Why?
|
| Time Factors | 2 | 2003 | 1742 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2005 | 626 | 0.050 |
Why?
|
| Adjuvants, Immunologic | 1 | 2002 | 107 | 0.050 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2001 | 28 | 0.050 |
Why?
|
| Integrins | 1 | 2001 | 51 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2002 | 237 | 0.050 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2001 | 56 | 0.050 |
Why?
|
| Cricetinae | 1 | 2001 | 238 | 0.050 |
Why?
|
| Escherichia coli Proteins | 1 | 2002 | 126 | 0.050 |
Why?
|
| Vaccines, Inactivated | 2 | 2015 | 14 | 0.050 |
Why?
|
| Chlamydia trachomatis | 1 | 2001 | 68 | 0.050 |
Why?
|
| Mice, Inbred Strains | 1 | 2000 | 116 | 0.050 |
Why?
|
| Immunoenzyme Techniques | 1 | 2000 | 108 | 0.050 |
Why?
|
| Estradiol | 1 | 2002 | 262 | 0.050 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2000 | 57 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2005 | 938 | 0.040 |
Why?
|
| Immunity, Innate | 2 | 2015 | 149 | 0.040 |
Why?
|
| Chlamydia Infections | 1 | 2001 | 196 | 0.040 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 1998 | 41 | 0.040 |
Why?
|
| Gene Expression | 1 | 2000 | 674 | 0.040 |
Why?
|
| HIV Seropositivity | 1 | 1998 | 190 | 0.040 |
Why?
|
| Drug Resistance, Fungal | 2 | 2008 | 32 | 0.030 |
Why?
|
| Male | 3 | 2011 | 20025 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2000 | 1207 | 0.030 |
Why?
|
| Laccase | 1 | 2015 | 7 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2015 | 27 | 0.030 |
Why?
|
| Kidney | 2 | 2011 | 337 | 0.030 |
Why?
|
| Eosinophils | 1 | 2014 | 20 | 0.030 |
Why?
|
| Goblet Cells | 1 | 2014 | 11 | 0.030 |
Why?
|
| Caenorhabditis elegans | 1 | 2014 | 78 | 0.030 |
Why?
|
| Protein Transport | 1 | 2014 | 302 | 0.030 |
Why?
|
| Calgranulin A | 1 | 2012 | 1 | 0.030 |
Why?
|
| Interleukin-23 | 1 | 2012 | 1 | 0.030 |
Why?
|
| Calgranulin B | 1 | 2012 | 4 | 0.030 |
Why?
|
| Disease Progression | 1 | 2014 | 601 | 0.030 |
Why?
|
| Phenotype | 1 | 2014 | 689 | 0.030 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2011 | 21 | 0.020 |
Why?
|
| Doxycycline | 1 | 2011 | 30 | 0.020 |
Why?
|
| Response Elements | 1 | 2011 | 56 | 0.020 |
Why?
|
| Interleukin-12 | 2 | 2002 | 47 | 0.020 |
Why?
|
| Spleen | 1 | 2011 | 199 | 0.020 |
Why?
|
| Interleukin-10 | 2 | 2002 | 75 | 0.020 |
Why?
|
| Interleukin-2 | 2 | 2002 | 89 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 893 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 515 | 0.020 |
Why?
|
| Formazans | 1 | 2008 | 5 | 0.020 |
Why?
|
| Tacrolimus | 1 | 2004 | 10 | 0.020 |
Why?
|
| Mice, Inbred ICR | 1 | 2004 | 40 | 0.020 |
Why?
|
| Umbilical Veins | 1 | 2003 | 17 | 0.010 |
Why?
|
| Denture, Partial | 1 | 2002 | 1 | 0.010 |
Why?
|
| Denture, Complete | 1 | 2002 | 2 | 0.010 |
Why?
|
| Salivary Proteins and Peptides | 1 | 2002 | 5 | 0.010 |
Why?
|
| Administration, Rectal | 1 | 2002 | 18 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2002 | 108 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 2002 | 46 | 0.010 |
Why?
|
| Mucous Membrane | 1 | 2001 | 34 | 0.010 |
Why?
|
| Adult | 3 | 2002 | 11712 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2001 | 189 | 0.010 |
Why?
|
| Premenopause | 1 | 2001 | 104 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2003 | 308 | 0.010 |
Why?
|
| Reference Values | 1 | 1998 | 212 | 0.010 |
Why?
|
| Pilot Projects | 1 | 1998 | 661 | 0.010 |
Why?
|
| Anti-HIV Agents | 1 | 1998 | 420 | 0.010 |
Why?
|
| Aged | 1 | 2002 | 6741 | 0.010 |
Why?
|